Skip to main content
. 2019 Jul 30;44(2):150–158. doi: 10.5114/ceji.2019.87066

Fig. 3.

Fig. 3

Correlations between the sIL-6R/IL-6 ratio with Juvenile Arthritis Disease Activity Score-27 (JADAS-27) and erythrocyte sedimentation rate (ESR) in systemic juvenile idiopathic arthritis (SJIA) patients treated with and without tocilizumab (TCZ). Correlations between sIL-6R/IL-6 ratio with JADAS-27 in SJIA patients treated (A) without TCZ (95 samples) and (B) with TCZ (69 samples). Correlations between sIL-6R/IL-6 ratio with ESR in SJIA patients treated (C) without TCZ (95 samples) and (D) with TCZ (69 samples)